Daily Archives: February 27, 2018


Upcoming Webinar: Developing an anti-HER2 breast cancer vaccine using advantageous Drosophila S2 cell protein expression and virus-like -particle display technologies

ExpreS2ion Biotechnologies and AdaptVac will be presenting at the free webinar on March 14 at 5PM CET / 4PM GMT / 12PM EDT / 9AM PDT, hosted by the leading science journal published by Elsevier, Vaccine. The webinar is titled “Developing a HER2-VLP vaccine for treatment of HER2-positive cancer; optimizing […]